Clinical Edge Journal Scan

Maternal migraine raises risk for childhood cancers in offspring


 

Key clinical point: Maternal migraine diagnosis is associated with a higher risk for several childhood cancers in offspring.

Major finding : A significant positive association was observed between maternal migraine and the risk for non-Hodgkin lymphoma (odds ratio [OR] 1.70; 95% CI 1.01-2.86), central nervous system tumors (OR 1.31; 95% CI 1.02-1.68; particularly glioma: OR 1.64; 95% CI 1.12-2.40), neuroblastoma (OR 1.75; 95% CI 1.00-3.08), and osteosarcoma (OR 2.60; 95% CI 1.18-5.76).

Study details: This study included children age < 20 years with cancers (cases) and birth year- and sex-matched (25:1) children without cancers (control individuals).

Disclosures: This study was supported by the US National Institutes of Health. The authors declared no conflicts of interest.

Source: Orimoloye HT et al. Maternal migraine and risk of pediatric cancers. Pediatr Blood Cancer. 2023 (Apr 26). doi: 10.1002/pbc.30385

Recommended Reading

Head-to-head comparison of migraine meds reveals top options
Migraine ICYMI
Commentary: Migraine and the relationship to gynecologic conditions, May 2023
Migraine ICYMI
Late response to CGRP monoclonal antibodies is frequent in migraine
Migraine ICYMI
Eptinezumab lowers monthly migraine days in patients with multiple treatment failures
Migraine ICYMI
Galcanezumab shows sustained response in episodic, chronic, and treatment-resistant migraine
Migraine ICYMI
Migraine: CGRP-mAb class switch beneficial among nonresponders or those experiencing gradual loss of efficacy
Migraine ICYMI
Serum alpha-CGRP level as a potential biomarker in chronic migraine
Migraine ICYMI
COVID-19 history worsens clinical course of migraine
Migraine ICYMI
Migraine raises severity of vasomotor symptoms in midlife women
Migraine ICYMI
Meta-analysis elucidates bidirectional association between psoriasis and migraine
Migraine ICYMI